Increasing Prevalence of Blood Related Disorders such as Blood Cancer, Anemia, Sickle Cell
Disease, Hemophilia, and Other Rare Blood Disorders is Expected to Drive the Disposable
Blood Bags Market Revenue
Rising prevalence of diseases such as cancer and various blood related disorder (anemia,
hemophilia, and sickle cell disease) is increasing demand for blood transfusion, which eventually
drives growth of the disposable blood bags market. For instance, according to Red Cross Blood
Organization facts of 2017 about blood needs, sickle cell disease affects 90,000 to 100,000 people
in the U.S. and approximately 1,000 babies are born with the disease each year. Sickle cell patients
often require blood transfusions throughout their lives.
For More Information @
https://www.coherentmarketinsights.com/market-insight/disposable-blood-bags-market-2170
Increasing number of cancer incidences worldwide is also a major factor driving the disposable
blood bags market’s growth. For instance, according to American Cancer Society, 2018, 1,735,350
new cancer cases and 609,640 cancer deaths are projected to occur in the U.S. by the end of 2018.
Majority of these patients will need blood, sometimes daily, during chemotherapy treatment.
Furthermore, according to the New York Blood Center, approximately 4.5 million Americans
receive blood transfusions each year and 40,000 pints are transfused each day in the country, to save
the lives of cancer patients, burn, accident, and trauma victims, mothers delivering babies, newborn
babies, transplant patients, surgery patients and others in need.
Disposable Blood Bags Market Restraints
Though the demand for blood transfusion is huge worldwide, there is a shortfall in blood supplies in
low-income countries due to lack of a robust infrastructure for blood collection, distribution, and
storage. In most of the emerging economies, there is no national blood service as a result
organizations are struggling to provide blood to meet the needs of the population.
Moreover, the medical infrastructure is also poor in these countries. Patients, in need of blood
transfusion, are often located at great distances from hospitals and clinics, pushing up mortality
rates. Production of disposable blood bags is stacked due to the presence of numerous stringent
standards and regulations starting from manufacturing to marking for disposable blood bags.
Disposable Blood Bags Market - Regional Insights
On the basis of region, the global disposable blood bags market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. In 2026, North America is expected
to hold the leading position in the global disposable blood bags market, owing to well-established
medical and healthcare infrastructure providing timely blood transfusion services. Growing
awareness among people for blood donation is also a major factor driving growth of the disposable
blood bags market. According to the Red Cross Blood Organization blood supply statistics of 2017,
an estimated 6.8 million people in the U.S. donate blood every year.
Disposable Blood Bags Market - Competitive Landscape
Key players operating in the global disposable blood bags market include AdvacarePharma,
Fresenius Kabi, Grifols, HLL Lifecare, Haemonetics Corporation, Macopharma, Neomedic, Poly
Medicure, SURU International, Span Healthcare, and TERUMO PENPOL. Use of biosafety
materials in the manufacturing of blood bags and favorable support from government authorities is
expected to create huge growth opportunities for disposable blood bag manufacturers.
Detailed Segmentation:
•Global Disposable Blood Bags Market, By Blood Bag Type: